The EU Joint Programme – Neurodegenerative Disease Research (JPND) will shortly launch a call for:
Multinational research projects on Health and Social Care for Neurodegenerative Diseases
There are an estimated 47 million people suffering from Alzheimer’s disease and related disorders worldwide. This figure is expected to double every 20 years as the population ages. As of today, neurodegenerative diseases are debilitating and still largely untreatable conditions.
Providing appropriate health and social care represents an increasingly significant responsibility for people who live with such diseases as well as their relatives and carers. Novel health and social care concepts focus on what people still can contribute in the context of the disease and how their environment may influence this process. Nevertheless, the availability and quality of health and social care services vary considerably across Europe and beyond.
Therefore, JPND will launch a call for multidisciplinary proposals that focus on one or several of the following research areas:
- Care pathways and programmes using the potential of patient involvement
- Factors influencing progression and prognosis of disease
- Outcome measures for patients and their informal carers
- Palliative care of patients
- Cost-effectiveness and affordability of interventions including ethical concerns
The following neurodegenerative diseases are included in the call:
- Alzheimer’s disease and other dementias
- Parkinson’s disease and PD‐related disorders
- Prion diseases
- Motor neuron diseases
- Huntington’s disease
- Spinocerebellar ataxia (SCA)
- Spinal muscular atrophy (SMA)
This will be a two-step call, expected to be launched in early January 2018, with a likely pre-proposal submission deadline in March 2018.
Further details will be provided with the official launch of the call.